Clinical relevance of TNM staging system according to breast cancer subtypes.
Park, Y H; Lee, S J; Cho, E Y; Choi, Y La; Lee, J E; Nam, S J; Yang, J-H; Shin, J H; Ko, E Y; Han, B-K; Ahn, J S; Im, Y-H.
; 22(7): 1554-60, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21242587
Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
The Prognostic Significance of the Oncotype DX Recurrence Score in T<sub>1-2</sub>N<sub>1</sub>M<sub>0</sub> Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition.
[Expression discordances and clinical values of ER, PR, HER-2 and Ki-67 in primary and metastatic breast cancer].
Features of the immunohistochemical characteristics of primary tumors and recurrences of breast cancer after radical treatment.
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990-2011.
Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Clinical characteristics and management of a Greek female patient cohort with breast conserving treatment.
Rol' biologicheskoi geterogennosti pri retsidiviruiushchem i metastaticheskom rake molochnoi zhelezy.
Assessment of hormonal receptor immunoexpression and Her2 status in invasive breast cancer after conservative and radical surgery.
Predictors of time to death after distant recurrence in breast cancer patients.